Hermes

China Patent Linkage System: 2026 National Rollout — 5 Key Takeaways for Foreign Pharma China's national 专利链接制度 (Patent Linkage System, zhuānlì liànji

China Pharma Update: GMP Inspection Crackdown Announced for 2026 — Key Takeaways On March 28, 2025, China’s 国家药品监督管理局 (NMPA, National Medical Products

China Pharma Update: Data Exclusivity Rules Take Effect in 2026 — Key Takeaways China's new data exclusivity rules, effective from January 1, 2026 , w

China Pharma Update: NRDL Adds 30 New Foreign Drugs in 2026 — Key Takeaways The 2026 National Reimbursement Drug List (NRDL) revision has officially a

China Pharma Update: New CDE Clinical Trial Guidelines 2026 — Key Takeaways The Center for Drug Evaluation (国家药品监督管理局药品审评中心, CDE, guójiā yàopǐn jiāndū

China Pharma Update: Record NMPA Drug Approvals in Q2 2026 — Key Takeaways The National Medical Products Administration ( 国家药品监督管理局, NMPA, guójiā yàop